Table 1.
Correlation between c-MET expression and clinicopathological features of patients with pancreatic cancer.
| Characteristics | n = 69 | c-MET | P-value | ||
|---|---|---|---|---|---|
| Low expression | High expression | ||||
| Age | ≤65 | 45 (65.2%) | 21(72.4%) | 24 (60.0%) | 0.317 |
| >65 | 24 (34.8%) | 8 (27.6%) | 16 (40.0%) | ||
| Sex | Male | 41 (59.4%) | 17 (58.6%) | 24 (60.0%) | >0.999 |
| Female | 28 (40.6%) | 12 (41.4%) | 16 (40.0%) | ||
| Tumour size | ≤4 | 54 (78.3%) | 24 (82.8%) | 30 (75.0%) | 0.559 |
| >4 | 15 (21.7%) | 5 (17.2%) | 10 (25.0%) | ||
| Pathologic stage | I+II | 41 (59.4%) | 19 (65.5%) | 22 (55.0%) | 0.460 |
| III+IV | 28 (40.6%) | 10 (34.5%) | 18 (45.0%) | ||
| T stage | T1+T2 | 43 (62.3%) | 20 (69.0%) | 23 (57.5%) | 0.451 |
| T3+T4 | 26 (37.7%) | 9 (31.0%) | 17 (42.5%) | ||
| N stage | N0 | 20 (29.0%) | 8 (27.6%) | 12 (30.0%) | 0.984 |
| N1 | 36 (52.2%) | 16 (55.2%) | 20 (50.0%) | ||
| N2 | 13 (18.8%) | 5 (17.2%) | 8 (20.0%) | ||
| M stage | M0 | 65 (94.2%) | 29 (100.0%) | 36 (90.0%) | 0.133 |
| M1 | 4 (5.8%) | 0 (0.0%) | 4 (10.0%) | ||
| Perineural invasion | Negative | 4 (5.8%) | 4 (13.8%) | 0 (0.0%) | 0.028 |
| Positive | 65 (94.2%) | 25 (86.2%) | 40 (100.0%) | ||